MX-2401   Click here for help

GtoPdb Ligand ID: 13518

Compound class: Synthetic organic
Comment: MX-2401 is a lipopeptide antibacterial compound and a semisynthetic analogue of the natural product amphomycin [2].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 37
Hydrogen bond donors 17
Rotatable bonds 32
Topological polar surface area 565.04
Molecular weight 1468.61
XLogP 2.51
No. Lipinski's rules broken 4

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCCCCCCCCCCC(=O)NC1=CC=C(C=C1)C(=O)NC(CC(=O)O)C(=O)NC2C(C)NC(=O)C3([H])CCCN3C(=O)C(C(C)C)NC(=O)C(C(C)NC(=O)CCN)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CC(=O)O)NC(=O)C(C(C)C(=O)O)NC(=O)C4([H])CCCCN4C2=O
Isomeric SMILES O=C1N2C(C(=O)NC(C(C(O)=O)C)C(=O)NC(CC(O)=O)C(=O)NCC(=O)NC(CC(O)=O)C(=O)NCC(=O)NC(C(NC(CCN)=O)C)C(=O)NC(C(C)C)C(=O)N3C(C(=O)NC(C)C1NC(C(NC(=O)C4=CC=C(NC(CCCCCCCCCCC)=O)C=C4)CC(O)=O)=O)(CCC3)[H])(CCCC2)[H]
InChI InChI=1S/C67H101N15O22/c1-7-8-9-10-11-12-13-14-15-21-46(83)73-40-24-22-39(23-25-40)57(93)75-43(32-52(91)92)60(96)80-56-38(6)72-61(97)45-20-18-29-82(45)65(101)53(35(2)3)78-64(100)55(37(5)71-47(84)26-27-68)77-49(86)34-70-58(94)41(30-50(87)88)74-48(85)33-69-59(95)42(31-51(89)90)76-63(99)54(36(4)67(103)104)79-62(98)44-19-16-17-28-81(44)66(56)102/h22-25,35-38,41-45,53-56H,7-21,26-34,68H2,1-6H3,(H,69,95)(H,70,94)(H,71,84)(H,72,97)(H,73,83)(H,74,85)(H,75,93)(H,76,99)(H,77,86)(H,78,100)(H,79,98)(H,80,96)(H,87,88)(H,89,90)(H,91,92)(H,103,104)
InChI Key FVWLJHLXFKFMJA-UHFFFAOYSA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Mechanism Of Action and Pharmacodynamic Effects Click here for help
MX-2401 inhibits peptidoglycan biosynthesis, thus interfering with bacterial cell wall synthesis, by binding to the membrane lipid carrier undecaprenyl phosphate [3]. This results in inhibition of the biosynthesis of the cell wall precursors lipids I and II and the teichoic acid precursor lipid III.